PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.28%
Revenue growth at 75-90% of 3141.T's 5.23%. Bill Ackman would push for innovation or market expansion to catch up.
3.84%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
-5.56%
Negative EBIT growth while 3141.T is at 17.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.34%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-15.18%
Negative net income growth while 3141.T stands at 2.38%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.18%
Negative EPS growth while 3141.T is at 2.40%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.18%
Negative diluted EPS growth while 3141.T is at 2.30%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 3141.T's 0.05%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
48.93%
10Y revenue/share CAGR under 50% of 3141.T's 110.96%. Michael Burry would suspect a lasting competitive disadvantage.
63.76%
5Y revenue/share CAGR 1.25-1.5x 3141.T's 57.92%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
39.15%
3Y revenue/share CAGR at 75-90% of 3141.T's 47.66%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
80.40%
Below 50% of 3141.T's 282.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
56.52%
5Y net income/share CAGR above 1.5x 3141.T's 18.81%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
44.96%
Below 50% of 3141.T's 118.82%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
137.78%
5Y equity/share CAGR 1.25-1.5x 3141.T's 101.79%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
66.52%
3Y equity/share CAGR 1.25-1.5x 3141.T's 48.78%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Cut dividends over 10 years while 3141.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.55%
Firm’s AR is declining while 3141.T shows 9.09%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.93%
Inventory is declining while 3141.T stands at 8.21%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.74%
Asset growth well under 50% of 3141.T's 4.68%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.67%
BV/share growth above 1.5x 3141.T's 1.57%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-38.23%
We’re deleveraging while 3141.T stands at 5.87%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
102.83%
SG&A growth well above 3141.T's 44.62%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.